Induction of hepatic apolipoprotein A-I gene expression by the isoflavones quercetin and isoquercetrin

Life Sciences

Volumn 110, Issue 1, 2014, Pages 8-14

  Haas, Michael J ^a   Onstead Haas, Luisa M ^b   Szafran Swietlik, Anna ^a   Kojanian, Hagop ^a   Davis, Tim ^b   Armstrong, Paul ^b   Wong, Norman C W ^c   Mooradian, Arshag D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Florida Community College at Jacksonville   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Coronary artery disease; Estrogen; Hepatocyte; High density lipoprotein; Phytosterol

Indexed keywords

APOLIPOPROTEIN A1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ISOFLAVONE DERIVATIVE; ISOQUERCETIN; MYRICETIN; QUERCETIN DERIVATIVE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA, HUMAN; FLAVONOID; FULVESTRANT; HIGH DENSITY LIPOPROTEIN; ISOQUERCITRIN; MESSENGER RNA; PHYTOSTEROL; QUERCETIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTESTINE CELL; LIVER CELL; MESSENGER RNA SYNTHESIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CACO 2 CELL LINE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HIGH-DENSITY LIPOPROTEIN; HYPOALPHALIPOPROTEINEMIA; LIVER; METABOLISM;

CORONARY ARTERY DISEASE; ESTROGEN; HEPATOCYTE; HIGH-DENSITY LIPOPROTEIN; PHYTOSTEROL;

APOLIPOPROTEIN A-I; CACO-2 CELLS; DOWN-REGULATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOIDS; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; HYPOALPHALIPOPROTEINEMIAS; ISOFLAVONES; LIPOPROTEINS, HDL; LIVER; PROMOTER REGIONS, GENETIC; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84907029375     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.06.014     Document Type: Article

References (37)

1. AIM-HIGH Investigators W.E. Boden, J.L. Probstfield, T. Anderson, B.R. Chaitman, and P. Desvignes-Nickens Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
2. J. Chen, D.A. Schwartz, T.A. Young, J.S. Norris, and J.D. Yager Identification of genes whose expression is altered during mitosuppression in livers of ethinyl estradiol-treated female rats Carcinogenesis 17 1996 2783 2786
3. Cholesterol Treatment Trialists' (CTT) Collaborators B. Mihaylova, J. Emberson, L. Blackwell, A. Keech, and J. Simes The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomized trials Lancet 380 2012 581 590
4. Cholesterol Treatment Trialists' (CTT) Collaboration C. Baigent, L. Blackwell, J. Emberson, L.E. Holland, and C. Reith Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials Lancet 376 2010 1670 1681
5. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
6. F.L. Crowe, A.W. Roddam, T.J. Key, P.N. Appleby, K. Overvad, and M.U. Jakobsen Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart Study Eur Heart J 32 2011 1235 1241
7. S. Egert, A. Bosy-Westphal, J. Seiberl, C. Kurbitz, U. Settler, and S. Plachta-Danielzik Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study Br J Nutr 102 2009 1065 1074
8. S. Egert, C. Boesch-Saadatmandi, S. Wolffram, G. Rimbach, and M.J. Muller Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype1,2 J Nutr 140 2010 278 284
9. P. Galluzzo, and M. Marino Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities Genes Nutr 1 2006 161 176
10. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamen, J.D. Berry, and W.B. Borden Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
11. C.M. Gorman, L.F. Moffat, and B.H. Howard Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells Mol Cell Biol 2 1982 1044 1051
12. A.M. Gotto Jr., and J.E. Moon Pharmacotherapies for lipid modification: beyond the statins Nat Rev Cardiol 10 2013 560 570
13. D.C. Harnish, M.J. Evans, M.S. Scicchitano, R.A. Bhat, and S.K. Karathanasis Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing J Biol Chem 273 1998 9270 9278
14. H.F. Hendricks, J.A. Westrate, T. van Vliet, and G.W. Meijer Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolemic and mildly hypercholesterolemic subjects Eur J Clin Nutr 53 1999 319 327
15. P. Herbomel, B. Bourachot, and M. Yaniv Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma Cell 39 1984 653 662
16. H.O. Jauregui, N.T. Hayner, J.L. Driscoll, R. Williams-Holland, M.H. Lipsky, and P.M. Galletti Trypan blue dye uptake and lactate dehydrogenase in adult rat hepatocytes - freshly isolated cells, cell suspensions, and primary monolayer cultures In Vitro 17 1981 1100 1110
17. T. Joy, and R.A. Hegele Is raising HDL a futile strategy for atheroprotection? Nat Rev Drug Discov 7 2008 143 155
18. S. Kalthoff, A. Winkler, N. Freiberg, M.P. Manns, and C.P. Strassburg Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A) J Hepatol 59 2013 797 804
19. J.K. Lam, S. Matsubara, K. Mihara, X.L. Zheng, A.D. Mooradian, and N.C. Wong Insulin induction of apolipoprotein AI, role of Sp1 Biochem 42 2003 2680 2690
20. K.W. Lee, N.J. Kang, Y.S. Heo, E.A. Rogozin, A. Pugliese, and M.K. Hwang Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine Cancer Res 68 2008 946 955
21. S.-M. Lee, J. Moon, Y. Cho, J.H. Chung, and M.J. Shin Quercetin up-regulates expressions of peroxisome proliferator-activated receptor γ, liver X receptor α, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line Nutrit Res 33 2013 136 145
22. P. Libby The forgotten majority: unfinished business in cardiovascular risk reduction J Am Coll Cardiol 46 2005 1225 1228
23. B. Mackness, and M. Mackness Anti-inflammatory properties of paraoxonase-1 in atherosclerosis Adv Exp Med Biol 660 2010 143 151
24. K. Murao, Y. Wada, T. Nakamura, A.H. Taylor, A.D. Mooradian, and N.C. Wong Effects of glucose and insulin on rat apolipoprotein A-I gene expression J Biol Chem 273 1998 18959 18965
25. M. Nomura, T. Takahashi, N. Nagata, K. Tsutsumi, S. Kobayashi, and T. Akiba Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells Biol Pharm Bull 31 2008 1403 1409
26. A. Perez, P. Ojeda, L. Ojeda, M. Salas, C.K. Rivas, and J.C. Vera Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrophostins Biochem 50 2011 8834 8845
27. R. Pradeepa, D. Prabhakaran, and V. Mohan Emerging economies and diabetes and cardiovascular disease Diabetes Technol Ther 14 Suppl. 1 2012 S59 S67
28. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, and M.D. Provenzano Measurement of protein using bicinchoninic acid Anal Biochem 150 1985 76 85
29. S. Solakidi, A.-M.G. Psarra, and C.E. Sekeris Differential subcellular distribution of estrogen receptor isoforms: localization of ERα in the nucleoli and ERβ in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines Biochim Biophys Acta 1745 2005 382 392
30. E. Talirevic, and S. Jelena Quercetin in the treatment of dyslipidemia Med Arh 66 2012 87 88
31. A.H. Taylor, A.H. Fox-Robichaud, C. Egan, J. Dionne, D.E. Lawless, and J. Raymond Estradiol decreases apolipoprotein AI expression in adult male rats via site B J Mol Endocrinol 25 2000 207 219
32. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci U S A 76 1979 4350 4354
33. F. Virgili, and M. Marino Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals beyond antioxidant activity Free Radic Biol Med 45 2008 1205 1216
34. B.F. Voight, G.M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, and M.K. Jensen Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomization study Lancet 380 2012 572 580
35. A.E. Wakeling, M. Dukes, and J. Bowler A potent specific pure antiestrogen with clinical potential Cancer Res 51 1991 3867 3873
36. E.H. Walker, M.E. Pacold, O. Perisic, L. Stephens, P.T. Hawkins, and M.P. Wymann Structural determinants of phosphoinositide-3-kinase inhibition by wortmanin, LY294002, quercetin, myricetin, and staurosporine Mol Cell 6 2000 609 619
37. N.C.W. Wong The beneficial effects of plant sterols on serum cholesterol Can J Cardiol 17 2001 715 721